The application dimension of the Breast Milk Substitute market delineates demand by end‑user context, shaping both product development and revenue streams. Infant nutrition dominates, accounting for roughly 70% of total sales, as pediatric formulas replace or supplement breastfeeding during the first year of life. A secondary tier, medical/clinical usage, represents about 20% and includes therapeutic formulas for infants with allergies, metabolic disorders, or premature birth complications; these products command premium pricing due to stringent regulatory oversight and specialized composition. The smallest but growing segment, adult/functional applications (≈10%), targets lactating mothers, elderly consumers, and health‑conscious adults seeking protein‑rich or fortified alternatives. Each application segment contributes distinctively to overall market size: infant formulas drive volume, medical formulas lift average selling price, and adult products expand the addressable consumer base, collectively defining the market’s growth trajectory and informing the Breast Milk Substitute segmentation strategy.